United States · FDA National Drug Code directory
MARGENZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70720-022_6a6d50c7-06ea-479c-83cc-f197a9e428c9
- Product NDC
- 70720-022
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- margetuximab-cmkb
- Labeler
- TerSera Therapeutics LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210115
- Source listing expiry
- 20261231
Source-listed ingredients
- MARGETUXIMAB — 25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →